Results 271 to 280 of about 743,928 (343)
Bridging Gaps in Fluid Choices and Management in Critically Ill Patients. [PDF]
Sundarsingh V, Kulkarni M, Kumar M.
europepmc +1 more source
To investigate the mechanisms about the enhanced buffering effect and morphological retention in fully lithiated Sn–Bi alloys, this study introduces a new bulk bimetallic Sn–Bi alloy with fine grains of uniformly distributed Sn and Bi alloys (≈50 nm) via cooling rate control. This design effectively relieves internal energy buildup and suppresses crack
Hyeon Seo Park+6 more
wiley +1 more source
Electrolyte disorders in the critically ill: a retrospective analysis. [PDF]
Bachmann KF+5 more
europepmc +1 more source
Reconfigurable Metamirrors Based on Compliant Mechanisms
Providing the basis for numerous practical applications, the reconfigurability of metadevices is of great importance. Through the integration of controlled mechanical deformation with chiral meta‐atoms, a compliant mechanism based metamirror is demonstrated for active control over the polarization of electromagnetic waves.
Galestan Mackertich‐Sengerdy+3 more
wiley +1 more source
Plasmapheresis in the critically ill patient.
Patrick M. Honoré+4 more
openalex +1 more source
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto+2 more
wiley +1 more source
Insulin: a wonder drug in the critically ill [PDF]
Beishuizen, A.+2 more
core +2 more sources
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq+4 more
wiley +1 more source